In short, PMN decreases ARTS-mediated degradation of XIAP by modulating the PINK1/Parkin pathway, thereby ameliorating 6-hydroxydopamine toxicity and α-synuclein accumulation in PD models of C. elegans and SH-SY5Y cell lines. This evidence concerns the gene PRKN and Parkinson disease.